InsiderClue
Stocks · Health care · Pharmaceutical Preparations

AN2 Therapeutics, Inc.

ANTX Clue Score37
United States Fiscal year ends December CIK 0001880438 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

37
Insider
Date
Role
Action
Shares
Price
Amount
Margaret M FitzPatrick
1 Sep 2026
Director
Buy
2,098
$5.53
$11.60K
Eric Easom
2 Jun 2025
Chief Executive Officer
Buy
10,000
$1.07
$10.67K
Margaret M FitzPatrick
28 May 2025
Director
Buy
8,610
$1.18
$10.13K
Robin Shane Readnour
10 Dec 2024
Director
Buy indirect
5,000
$1.49
$7.47K
Robin Shane Readnour
10 Dec 2024
Director
Buy indirect
5,000
$1.49
$7.46K
Robin Shane Readnour
9 Dec 2024
Director
Buy indirect
18,483
$1.43
$26.41K
Robin Shane Readnour
9 Dec 2024
Director
Buy indirect
12,289
$1.43
$17.58K
Robin Shane Readnour
6 Dec 2024
Director
Buy indirect
6,517
$1.45
$9.43K
Robin Shane Readnour
6 Dec 2024
Director
Buy indirect
12,711
$1.45
$18.37K
Joseph S Zakrzewski
27 Nov 2024
Director
Buy
2,000
$1.40
$2.80K
Robin Shane Readnour
27 Nov 2024
Director
Buy indirect
25,000
$1.42
$35.42K
Robin Shane Readnour
27 Nov 2024
Director
Buy indirect
25,000
$1.42
$35.42K
Robin Shane Readnour
26 Nov 2024
Director
Buy indirect
12,500
$1.39
$17.43K
Robin Shane Readnour
26 Nov 2024
Director
Buy indirect
12,500
$1.39
$17.42K
Robin Shane Readnour
20 Nov 2024
Director
Buy indirect
25,000
$1.15
$28.87K
Robin Shane Readnour
20 Nov 2024
Director
Buy indirect
25,000
$1.16
$29.00K
Joseph S Zakrzewski
19 Nov 2024
Director
Buy
5,000
$1.01
$5.05K
Robin Shane Readnour
19 Nov 2024
Director
Buy indirect
75,000
$1.04
$77.73K
Robin Shane Readnour
19 Nov 2024
Director
Buy indirect
75,000
$1.03
$77.53K
Eric Easom
18 Nov 2024
Chief Executive Officer
Buy indirect
50,000
$1.00
$49.97K
Joseph S Zakrzewski
18 Nov 2024
Director
Buy
20,000
$1.00
$20.00K
Braden Michael Leonard
14 Aug 2024
10% owner
Buy indirect
1,500,000
$1.04
$1.56M
Ra Capital Management, L.p.
18 Aug 2023
10% owner
Buy indirect
1,777,778
$9.00
$16.00M
Eric Easom
15 May 2023
Chief Executive Officer
Buy indirect
10,000
$5.38
$53.77K
Ra Capital Management, L.p.
4 Aug 2022
10% owner
Buy indirect
100
$7.99
$799.00
Ra Capital Management, L.p.
3 Aug 2022
10% owner
Buy indirect
1,809
$7.48
$13.53K
Ra Capital Management, L.p.
27 Jul 2022
10% owner
Buy indirect
8,281
$7.91
$65.50K
Ra Capital Management, L.p.
26 Jul 2022
10% owner
Buy indirect
14,938
$7.71
$115.17K
Ra Capital Management, L.p.
21 Jun 2022
10% owner
Buy indirect
302
$7.99
$2.41K
Ra Capital Management, L.p.
14 Jun 2022
10% owner
Buy indirect
61,424
$7.97
$489.40K
Ra Capital Management, L.p.
13 Jun 2022
10% owner
Buy indirect
20,000
$7.90
$158.00K
Ra Capital Management, L.p.
29 Mar 2022
10% owner
Buy indirect
115,613
$15.00
$1.73M
Ra Capital Management, L.p.
29 Mar 2022
10% owner
Buy indirect
1,551,053
$15.00
$23.27M
Kabeer Aziz
29 Mar 2022
Director
Buy indirect
166,666
$15.00
$2.50M
Adjuvant Global Health Technology Fund, L.P.
29 Mar 2022
10% owner
Buy indirect
166,666
$15.00
$2.50M
Robin Shane Readnour
29 Mar 2022
Director
Buy indirect
82,618
$15.00
$1.24M
Robin Shane Readnour
29 Mar 2022
Director
Buy indirect
70,716
$15.00
$1.06M
Show all 140 transactions →

What was left out

Form 4 filings counted 186
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 2
Sales at will 84
Transactions with no price 0
Shares from compensation/vesting 9,487,058
Sales filed before the plan box existed 22
History held since 31 Mar 2022